SavedAdd your journal

Journals / Türk Fertilite Dergisi / 2005 / Cilt: 13 - Sayı: 3

Ovulation stimulation in polycystic ovarian syndrome

Polikistik over sendromunda ovulasyon stimulasyonu

FÜSUN BELGİN SELAM
Erman Münire AKAR
Mine İREZ
Pages
219–227
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The current review summarizes the therapeutic alternatives and current approach for ovarian stimulation in patients with PCOS.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Patients with PCOS demonstrate many problems, such as excessive body weight and hyperinsulinaemia, that render management more complex.
📊
Key Findings & Data:Prior to treatment for infertility, the PCOS patient should be thoroughly evaluated for other causes of infertility, hyperinsulinaemia, and other general health related problems.
💡
Conclusion & Impact:The current review summarizes the therapeutic alternatives and current approach for ovarian stimulation in patients with PCOS.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Kısırlık · Ovülasyon uyarılması · Polikistik yumurtalık sendromu

Abstract

Patients with PCOS demonstrate many problems, such as excessive body weight and hyperinsulinaemia, that render management more complex. Prior to treatment for infertility, the PCOS patient should be thoroughly evaluated for other causes of infertility, hyperinsulinaemia, and other general health related problems. Ovarian stimulation for IVF carries the risk of severe hyperstimulation, which should be controlled in most cases with preventive measures. In-vitro ma¬turation (IVM) of oocytes retrieved from non-stimulated or minimally stimulated cycles represents a viable option that could be considered . The current review summarizes the therapeutic alternatives and current approach for ovarian stimulation in patients with PCOS.

Özet

Amaç: Polikistik over sendromlu (PCOS) hastalarda izlenen kilo artışı ve hiperinsülinemi gibi pek çok problem tedaviyi daha kompleks bir duruma getirmektedir. PCOS’lu hastalar infertilite tedavisi öncesinde, infertilitenin diğer sebepleri, hiperinsülinemi ve genel sağlık sorunları yönünden detaylı olarak değerlendirilmelidir. In vitro fertilizasyon (IVF) öncesi over stimülasyonunda ciddi hiperstimülasyon riski önleyici yaklaşımlarla kontrol edilmelidir. Hafif stimülasyon uygulanan ya da uygulanmayan siklüslerden elde edilen oositlerin in vitro matürasyonu (IVM) düşünülmesi gereken geçerli bir tedavi seçeneğini temsil etmektedir. Bu derlemede PCOS’lu hastalarda over stimülasyonundaki tedavi seçenekleri ve güncel yaklaşımlar özetlenmektedir.

🔖

Cite This Article

SELAM, F. B., AKAR, E. M., İREZ, M. (2005). Ovulation stimulation in polycystic ovarian syndrome. Türk Fertilite Dergisi, Cilt: 13 - Sayı: 3, 219–227. https://ajindex.com/articles/409092

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Stein IF, Leventhal ML. Amenorrhea associated with bilateral polycy sue ovaries, Am J Obstet Gynecol 1935;29:181
  2. The Rotterdam ESHRE/ASRM Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long term health risks related to polycystic ovary syndrome. Fertil Steril 2003;81(l):19-25
  3. Tomas, C, Nuojua-Huttunen, S., and Martikainen, H. Pretreatment transvaginal ultrasound examination predicts ovarian responsiveness to gonadotrophins in in-vitro fertilization. Hum Reprod 1997; 12(2):220-3
  4. Hodgen G, Kenigsburg D, Collins R, Scheneken R. Selection of the dominant ovarian follicle and enhancement of the natural cycle. Ann N Y Acad Scie 1985; 442:23-27
  5. Adashi EY. Clomiphene citrate initiated ovulation. A clinical update. Sem Reprod Endocrinol 1986;4: 255-275
  6. Gysler M, March CM et al. A decade's experience with an individualized clomiphene treatment regimen including its effect on the postcoital test. Fertil Steril 1982;37:161-167
  7. Prough SG, Aksel S, Yeoman R. Luteinizing hormone bioactivity and variable responses to clomiphene citrate in chronic anovulation. Fertil Steril 1990;54:799-804
  8. O Herlihy C, Pepperell RJ, Robinson HP. Ultrasound timing of human chorionic gonadotropin administration in clomiphene stimulated cycles. Obstet Gynecol 1982;59:40-45
  9. Daly DC, Walters CA et at. A randomized study of dexamethasone in ovulation induction with clomipene citrate. Fertil Steril 1984;41:844-48
  10. Hoffman D, Lobo RA. Serum dehidtoepiandrosterone sulphate and the use of clomiphene citrate in anovulatory women. Fertil Steril 1985; 43:196-199
  11. Gorlitsky GA, Kase NG, SperoffL. Ovulation and pregnancy rates.with clomiphene citrate. Obstet Gynecol 1978;51:265-269
  12. Hammond MG, Hamle JK, Talbert LM. Factors affecting the pregnancy rate in clomiphene citrate induction of ovulation. Fertil Steril 1983;62:196-203
  13. ESHRE. Female infertility: treatment options for complicated cases. The ESHRE Capri Workshop. Hum Reprod 1997;12:1191 -6
  14. Asch RH, Greenblatt RB. Update on the safety and efficacy of clomiphene citrate as a therapeutic agent. J Reprod Med 1976; 17:175-80
  15. Stephan F, Diana H. Ovulation induction: Gonadotropins: in Reproductive Endocrinology, Surgery and Technology. Eli Y Adoshi, John A Rock, Zev Rozenwaks (Eds.) 1996. Lippincott-Ra- ven Pub. PA, New York, p: 1208-23
  16. Dale O, Tanbo T, Lunde O. Ovulation induction with low dose follicle stimulating hormone in women with the pol